Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2026-02-19 @ 1:48 PM
Study NCT ID:
NCT01168804
Status:
COMPLETED
Last Update Posted:
2013-11-25
First Post:
2010-07-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Plus Bortezomib Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
Sponsor:
Austrian Forum Against Cancer
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BBD
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None